Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Hum Pathol. 2021 Nov 19;119:69–78. doi: 10.1016/j.humpath.2021.11.004

Table 1.

Clinical features of the patients’ cohort.

Case Age/
gender
Race/
ethnicity
Reconstruction Primary disease Time to
disease
(years)
Specimen
type
Stage Treatment Follow-
up
(months)
Outcome
1 60/M NA Ileal conduit Bladder exstrophy 40 Resection pT4N1 Surgery 7 AWOD
2 53/F White Ileal conduit Vesicoureteral reflux 48 Resection pT1Nx Surgery 48 AWOD
3 58/F White Ileal conduit Urothelial carcinoma 2 Resection T3Nx Chemotherapy Radiation 82 AWOD
4 59/M White Ileal conduit Bladder exstrophy 58 Resection pT2N2b Surgery 7 DOU
5 38/M White Ileal conduit Obstructive uropathy s/p kidney transplant 36 Resection pT2N2 Surgery Chemotherapy 9.5 LTF
6 36/M White Gastrocystoplasty Reflux nephropathy s/p kidney transplant 24 Resection pT3aN2 Surgery Chemotherapy 8.5 DOD
7 29/M White Gastrocystoplasty Renal dysplasia 26 TURBT pT2N3M1 Surgery Chemotherapy 18 AWD
8 50/F White Colo-cystoplasty converted to ileal conduit End-stage bladder s/p chemotherapy 44 Biopsy pT1NxM1 Radiation Immunotherapy 7 AWD
9 59/M White Ileal conduit Diabetes insipidus and bladder dysfunction Childhood Biopsy NA Chemotherapy 2 AWD
10 70/M White Indiana pouch Leiomyosarcoma bladder 6 Resection pT2N1a Surgery Chemotherapy 24 LTF
11 57/M NA Augmentation cystoplasty NA Childhood Resection pT1Nx Surgery 63 AWOD

Abbreviations: NA, not available; AWOD, alive without disease; AWD, alive with disease; DOU, died of unknown cause; DOD, died of disease; LTF, lost to follow-up.